SEC Form 4 · accession 0001209191-15-074461
ROCKWELL MEDICAL, INC. · RMTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Dennis Pratt
Officer — VP of Drug Development
Period of report
Oct 2, 2015
Accepted (ET)
Oct 6, 2015 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001041024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 2, 2015 | A | 165,000 | $0.00 | A | 325,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $8.23 | Oct 2, 2015 | A | 215,000 | A | — | Oct 2, 2025 | Common Stock | 215,000 | 215,000 | D |
Explanation of responses
- F1Restricted stock grant. Restrictions lapse as to all of the shares on May 10, 2017.
- F2The option vests in three equal installments on October 2, 2016, October 2, 2017, and October 2, 2018.